Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audrey Kauffmann

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Molecular Cancer Therapeutics|August 5, 2020
The Discovery of SWI/SNF Chromatin Remodeling Activity as a Novel and Targetable Dependency in Uveal MelanomaFlorencia Rago, GiNell Elliott, Ailing Li, et al.
Cancer Discovery|June 5, 2016
CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic RegionsDiana M Munoz, Pamela J Cassiani, Li Li, et al.
Science Advances|July 3, 2021
Systematic dissection of transcriptional regulatory networks by genome-scale and single-cell CRISPR screensRui Lopes, Kathleen Sprouffske, Caibin Sheng, et al.
Molecular Cancer Therapeutics|March 11, 2014
Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trialsChristine Fritsch, Alan Huang, Christian Chatenay-Rivauday, et al.
Cancer Research|August 24, 2018
Dose and Schedule Determine Distinct Molecular Mechanisms Underlying the Efficacy of the p53-MDM2 Inhibitor HDM201Sébastien Jeay, Stéphane Ferretti, Philipp Holzer, et al.
Nature Medicine|December 24, 2013
Pharmacological and genomic profiling identifies NF-κB-targeted treatment strategies for mantle cell lymphomaRami Rahal, Mareike Frick, Rodrigo Romero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2014
Pan-PIM kinase inhibition provides a novel therapy for treating hematologic cancersPablo D Garcia, John L Langowski, Yingyun Wang, et al.
Cancer Research Communications|November 1, 2024
Dynamic Evolution of Fibroblasts Revealed by Single-Cell RNA Sequencing of Human Pancreatic CancerSlavica Dimitrieva, Jon M Harrison, Jonathan Chang, et al.
Nature Medicine|October 20, 2015
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug responseHui Gao, Joshua M Korn, Stéphane Ferretti, et al.
Nature|May 10, 2019
Next-generation characterization of the Cancer Cell Line EncyclopediaMahmoud Ghandi, Franklin W Huang, Judit Jané-Valbuena, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Molecular Cancer Therapeutics|August 5, 2020
The Discovery of SWI/SNF Chromatin Remodeling Activity as a Novel and Targetable Dependency in Uveal MelanomaFlorencia Rago, GiNell Elliott, Ailing Li, et al.
Cancer Discovery|June 5, 2016
CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic RegionsDiana M Munoz, Pamela J Cassiani, Li Li, et al.
Science Advances|July 3, 2021
Systematic dissection of transcriptional regulatory networks by genome-scale and single-cell CRISPR screensRui Lopes, Kathleen Sprouffske, Caibin Sheng, et al.
Molecular Cancer Therapeutics|March 11, 2014
Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trialsChristine Fritsch, Alan Huang, Christian Chatenay-Rivauday, et al.
Cancer Research|August 24, 2018
Dose and Schedule Determine Distinct Molecular Mechanisms Underlying the Efficacy of the p53-MDM2 Inhibitor HDM201Sébastien Jeay, Stéphane Ferretti, Philipp Holzer, et al.
Nature Medicine|December 24, 2013
Pharmacological and genomic profiling identifies NF-κB-targeted treatment strategies for mantle cell lymphomaRami Rahal, Mareike Frick, Rodrigo Romero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2014
Pan-PIM kinase inhibition provides a novel therapy for treating hematologic cancersPablo D Garcia, John L Langowski, Yingyun Wang, et al.
Cancer Research Communications|November 1, 2024
Dynamic Evolution of Fibroblasts Revealed by Single-Cell RNA Sequencing of Human Pancreatic CancerSlavica Dimitrieva, Jon M Harrison, Jonathan Chang, et al.
Nature Medicine|October 20, 2015
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug responseHui Gao, Joshua M Korn, Stéphane Ferretti, et al.
Nature|May 10, 2019
Next-generation characterization of the Cancer Cell Line EncyclopediaMahmoud Ghandi, Franklin W Huang, Judit Jané-Valbuena, et al.
Pageof 5